Aterian (ATER) Proxy filing summary

Executive summary

• Board unanimously recommends voting in favor of all eight proposals at the July 10, 2026, Special Meeting.

• Strategic review led to approval of an $18 million asset sale and a $7 million investment to reposition for growth.

• Net proceeds from the asset sale expected to return $0.85 to $1.14 per share to stockholders, with distributions anticipated in Q3 2026.

• Strategic investor waives rights to asset sale proceeds, ensuring full benefit to stockholders.

• Forward-looking statements highlight risks related to transaction completion, personnel retention, and market conditions.

Voting matters and shareholder proposals

• Eight proposals include asset sale, director elections, change of control, related party issuance, stock issuance, reverse stock split, authorized stock increase, and adjournment.

• Asset sale involves selling leading e-commerce brands for $18 million.

• Director nominees are Avraham Ben-Tzi (term through 2027) and David Natan (term through 2028).

• Proposals address Nasdaq listing rules for share issuance and corporate actions.

Board of directors and corporate governance

• Board conducted a broad strategic review in late 2025, leading to the proposed transactions.

• Board unanimously approved the asset sale and investment transaction.

• Board retains discretion on reverse stock split ratio and authorized share increase.